Cargando…

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins

Presently, there is large interest in analysing the interactions in vitro with plasma proteins of some novel antitumor ruthenium(III) complexes that are in preclinical or clinical phase. The joint application of separation and spectroscopic techniques provides valuable information on the nature and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messori, L., Vilchez, F. Gonzales, Vilaplana, R., Piccioli, F., Alessio, E., Keppler, B.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2000
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365243/ https://www.ncbi.nlm.nih.gov/pubmed/18475965 http://dx.doi.org/10.1155/MBD.2000.335

Ejemplares similares

Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
por: Morbidelli, L, et al.
Publicado: (2003)

Protein-binding Properties of two Antitumour Ru(III) Complexes to Human Apotransferrin and Apolactoferrin
por: Kratz, F., et al.
Publicado: (1994)

Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line
por: Kratz, F., et al.
Publicado: (1996)

Synthesis, Structure and Antitumour Properties of a New 1,2-Propylenediaminetetraacetate-Ruthenium(III) Compound
por: Vilaplana, R., et al.
Publicado: (1995)

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents
por: Pujante-Galián, María Angeles, et al.
Publicado: (2020)

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity
por: Demoro, Bruno, et al.
Publicado: (2019)

Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties
por: Mestroni, G., et al.
Publicado: (1994)

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III)
por: Lipponer, Kari-Georg, et al.
Publicado: (1996)

Synthesis and Characterization of Novel Ruthenium(III) Complexes with Histamine
por: Kljun, Jakob, et al.
Publicado: (2010)

Antimetastatic activity of novel ruthenium (III) pyridine complexes
por: Gu, Liwei, et al.
Publicado: (2016)

Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles
por: Novak, Maria S., et al.
Publicado: (2016)

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
por: Alessio, Enzo, et al.
Publicado: (2019)

Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells
por: Mühlgassner, Gerhard, et al.
Publicado: (2012)

New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents
por: de Melo, Ariane C.C., et al.
Publicado: (2019)

Effects of Hypoxia and Transferrin on Toxicity and DNA Binding of Ruthenium Antitumor Agents in Hela Cells
por: Frasca, D., et al.
Publicado: (1996)

Solution speciation and human serum protein binding of indium(III) complexes of 8-hydroxyquinoline, deferiprone and maltol
por: Dömötör, Orsolya, et al.
Publicado: (2022)

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009)

X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
por: Bijelic, Aleksandar, et al.
Publicado: (2016)

New Tumor-Inhibiting Metal Complexes. Chemistry and Antitumor Properties
por: Keppler, B. K., et al.
Publicado: (1994)

The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study
por: Messori, Luigi, et al.
Publicado: (1996)

Binding of Stimuli-Responsive Ruthenium Aqua Complexes with 9-Ethylguanine
por: Maeda, Atsuki, et al.
Publicado: (2023)

Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo
por: Savic, Maja, et al.
Publicado: (2020)

Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

Development and Application of Ruthenium(II) and Iridium(III) Based Complexes for Anion Sensing
por: Rashid, Ambreen, et al.
Publicado: (2023)

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
por: Riccardi, Claudia, et al.
Publicado: (2019)

The Ruthenium Nitrosyl Moiety in Clusters: Trinuclear Linear μ-Hydroxido Magnesium(II)-Diruthenium(II), μ(3)-Oxido Trinuclear Diiron(III)–Ruthenium(II), and Tetranuclear μ(4)-Oxido Trigallium(III)-Ruthenium(II) Complexes
por: Stepanenko, Iryna, et al.
Publicado: (2021)

Conjugates of Gold Nanoparticles and Antitumor Gold(III) Complexes as a Tool for Their AFM and SERS Detection in Biological Tissue
por: Bondžić, Aleksandra M., et al.
Publicado: (2019)

Ruthenium polypyridyl complexes and their modes of interaction with DNA: Is there a correlation between these interactions and the antitumor activity of the compounds?
por: Corral, Eva, et al.
Publicado: (2008)

Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC–ICP–MS
por: Klose, Matthias H. M., et al.
Publicado: (2018)

Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds
por: Sunder A, Shyam, et al.
Publicado: (2013)

Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds
por: Starosta, Radoslaw, et al.
Publicado: (2023)

Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
por: Hanif, Muhammad, et al.
Publicado: (2013)

Ruthenium(II)(η(6)-arene) Complexes of Thiourea Derivatives: Synthesis, Characterization and Urease Inhibition
por: Hanif, Muhammad, et al.
Publicado: (2014)

Special Issue on Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2017)

Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity
por: Liu, Suyan, et al.
Publicado: (2018)

Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells
por: Dalla Pozza, Maria, et al.
Publicado: (2021)

Alkyne Functionalization of a Photoactivated Ruthenium Polypyridyl Complex for Click-Enabled Serum Albumin Interaction Studies
por: Busemann, Anja, et al.
Publicado: (2020)

Oxidative Stress and Antimicrobial Activity of Chromium(III) and Ruthenium(II) Complexes on Staphylococcus aureus and Escherichia coli
por: Páez, Paulina L., et al.
Publicado: (2013)

Physicochemical Studies and Anticancer Potency of Ruthenium η(6)-p-Cymene Complexes Containing Antibacterial Quinolones
por: Kljun, Jakob, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rd47obpa6elupv1gbhikk4iiu4